Pathology-derived estimates of tumor-infiltrating lymphocytes (PaTILS) did not differ between the response groups or between pre- and post-pET (Figure 2F), but we observed highly significant differences in Ki67 staining between R and NR cases at baseline and post-pET (Figure 2G). The gene discussed is MKI67; the disease is neoplasm.